[go: up one dir, main page]

CN1116028C - Nanometer-size realgar and its preparation - Google Patents

Nanometer-size realgar and its preparation Download PDF

Info

Publication number
CN1116028C
CN1116028C CN 00116045 CN00116045A CN1116028C CN 1116028 C CN1116028 C CN 1116028C CN 00116045 CN00116045 CN 00116045 CN 00116045 A CN00116045 A CN 00116045A CN 1116028 C CN1116028 C CN 1116028C
Authority
CN
China
Prior art keywords
realgar
drug
control
powder
chinese medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN 00116045
Other languages
Chinese (zh)
Other versions
CN1288723A (en
Inventor
谢长生
杨祥良
徐辉碧
吴隽
黄开勋
邓英
吴际洲
金满文
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Huazhong University of Science and Technology
Original Assignee
Huazhong University of Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Huazhong University of Science and Technology filed Critical Huazhong University of Science and Technology
Priority to CN 00116045 priority Critical patent/CN1116028C/en
Publication of CN1288723A publication Critical patent/CN1288723A/en
Application granted granted Critical
Publication of CN1116028C publication Critical patent/CN1116028C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

本发明是把纳米技术引入到中药雄黄的制备,即把雄黄制成纳米级(1~100纳米)的细微粉粒,从而赋予雄黄以更高的药效和抗肿瘤作用。由于雄黄不溶于水,一般服用方法将其研磨成粉末入药。研究表明,中药产生的药理效应不能唯一地归功于该药物特有的化学组成,还与药物的物理状态密切相关。因此纳米雄黄经药效实验证明可明显提高药效,而且,纳米雄黄可望成为一类新的,高效低毒的抗肿瘤药。本发明实现纳米雄黄的方法是:(1)温度可控真空或惰性气氛高能球磨法;(2)超音速气流粉碎法。

Figure 00116045

The invention introduces the nanotechnology into the preparation of the traditional Chinese medicine realgar, that is, the realgar is made into nanoscale (1-100 nanometers) fine powder, thereby endowing the realgar with higher drug efficacy and antitumor effect. Since realgar is insoluble in water, it is generally taken by grinding it into powder and taking it as medicine. Studies have shown that the pharmacological effects of traditional Chinese medicine cannot be solely attributed to the unique chemical composition of the drug, but are also closely related to the physical state of the drug. Therefore, nano-realgar has been proved by drug efficacy experiments to significantly improve drug efficacy, and nano-realgar is expected to become a new class of antitumor drug with high efficiency and low toxicity. The method for realizing the nanometer realgar of the present invention is: (1) a temperature-controllable vacuum or inert atmosphere high-energy ball milling method; (2) a supersonic airflow pulverization method.

Figure 00116045

Description

纳米雄黄及其制备方法Nano realgar and its preparation method

技术领域technical field

本发明所涉及的是中药及其制备方法。把纳米技术引入到中药雄黄的制备,即将雄黄制成纳米级的细微粉粒,从而赋予雄黄以更高的药效。而纳米技术是指0.1-100纳米(nanometer,简称纳米nm)材料尺度上的研究和应用。What the present invention relates to is traditional Chinese medicine and preparation method thereof. Introduce nanotechnology to the preparation of realgar, a traditional Chinese medicine, that is, make realgar into nano-scale fine powder, so as to endow realgar with higher efficacy. Nanotechnology refers to the research and application on the material scale of 0.1-100 nanometers (nanometer, nanometer for short).

背景技术Background technique

矿物中药雄黄,主要成分为二硫化二砷(As2S2)。雄黄的功能与主治为解毒杀虫,燥湿祛痰,截疟,用于痈肿疔疮,蛇虫咬伤,虫积腹痛,惊痫,疟疾等。现代药理研究表明,雄黄具有抗病原微生物作用,抗肿瘤作用等。Realgar, a mineral traditional Chinese medicine, is mainly composed of arsenic disulfide (As 2 S 2 ). The functions and indications of realgar are to detoxify and kill insects, dry dampness and expel phlegm, cut off malaria, and be used for carbuncle and furuncle, snake and insect bites, abdominal pain caused by parasites, epilepsy, malaria, etc. Modern pharmacological studies have shown that realgar has anti-pathogenic microorganisms and anti-tumor effects.

雄黄难溶于水,服用方法一般是将其研磨成粉末入药。但还未见有将雄黄制成纳米级粉末的报道。Realgar is insoluble in water, and it is generally taken as medicine by grinding it into powder. But there is no report that realgar is made into nanoscale powder.

过去一般认为中药防病治病的物质基础来自于生物活性成分或活性化学组分。但是中药产生的药理效应不能唯一地归功于该药物特有的化学组成,还可能与药物的物理状态密切相关。由于传统的中药加工方法缺少先进的加工手段,许多药物的生物利用度低,药效难于得到充分的发挥。In the past, it was generally believed that the material basis of traditional Chinese medicine for disease prevention and treatment came from biologically active components or active chemical components. However, the pharmacological effects of traditional Chinese medicine cannot be solely attributed to the unique chemical composition of the medicine, and may also be closely related to the physical state of the medicine. Due to the lack of advanced processing methods in traditional Chinese medicine processing methods, the bioavailability of many medicines is low, and it is difficult to fully exert their efficacy.

发明内容Contents of the invention

本发明旨在将雄黄制成纳米粒径(1~100nm)的粉末以提高中药雄黄的药效,以及雄黄颗粒在纳米状态的更高的抗肿瘤作用。The invention aims at making the realgar into powder with nanometer particle size (1-100nm) to improve the drug effect of the traditional Chinese medicine realgar and the higher anti-tumor effect of the realgar particles in the nanometer state.

本发明使用了两种制备纳米雄黄的方法,(1)将0.1~2.0公斤原料雄黄粉末置于配有深冷外套的真空或惰性气体气氛的球磨罐中,同时装入1.0~20公斤的磨球,使球与雄黄粉比保持在15∶1~5∶1范围,控制高能球磨机的转速和时间,使其在200~400RPM(转/分)和2~60小时范围,以获取平均粒径小于100纳米的雄黄粉末。球磨机采用双层外套结构,其外套配有液氮注入口和温度检测装置,操作温度是通过调节注入到双层外套液氮的量来控制的,控制范围是-50℃~100℃。高能球磨机内操作气氛为真空或惰性气体;(2)超音速气流粉碎法:采用市售气流粉碎机,机内操作气氛为惰性气体,温度可控制范围是-50℃~100℃。上述两种方法所用的惰性气体是氮气和二氧化碳。经电子显微镜观察,这两种方法制备的雄黄粉末粒径全都达到纳米级,即1~100纳米。The present invention uses two kinds of methods for preparing nano-realgar, (1) 0.1-2.0 kilograms of raw material realgar powder is placed in a vacuum or inert gas atmosphere ball mill jar equipped with a cryogenic jacket, and 1.0-20 kilograms of milling jars are simultaneously loaded. Balls, keep the ratio of balls and realgar powder in the range of 15:1 to 5:1, control the speed and time of the high-energy ball mill so that it is in the range of 200 to 400 RPM (rev/min) and 2 to 60 hours to obtain the average particle size Realgar powder smaller than 100 nanometers. The ball mill adopts a double-layer jacket structure, and the jacket is equipped with a liquid nitrogen injection port and a temperature detection device. The operating temperature is controlled by adjusting the amount of liquid nitrogen injected into the double-layer jacket, and the control range is -50°C to 100°C. The operating atmosphere in the high-energy ball mill is vacuum or inert gas; (2) Supersonic jet milling method: use a commercially available jet mill, the operating atmosphere in the machine is inert gas, and the temperature can be controlled within the range of -50°C to 100°C. The inert gases used in the above two methods are nitrogen and carbon dioxide. Observed by an electron microscope, the particle diameters of the realgar powder prepared by these two methods all reach the nanometer level, that is, 1 to 100 nanometers.

具体实施方式Detailed ways

取纳米粉末雄黄和一般雄黄粉末作药效对比实验。以下两个实验是将雄黄制备了几种不同粒径的雄黄粉末样品,目的在于研究粉末的粒径特别是纳米尺度时对其药理作用的影响。实验(1)对小鼠肉瘤S180体外肿瘤细胞的抑制作用的研究Take nano powder realgar and common realgar powder for drug effect comparison experiment. In the following two experiments, several realgar powder samples with different particle sizes were prepared from realgar, with the purpose of studying the influence of the particle size of the powder, especially the nanoscale, on its pharmacological effects. Experiment (1) Study on Inhibition of Mouse Sarcoma S 180 Tumor Cells in Vitro

本实验材料:雄黄购自湖北中医研究院药房,昆明种小白鼠(约20g)、S180荷瘤种鼠均购自同济医科大学实验动物中心。本实验方法:Materials for this experiment: realgar was purchased from the pharmacy of Hubei Institute of Traditional Chinese Medicine, and Kunming mice (about 20 g) and S 180 tumor-bearing mice were purchased from the Experimental Animal Center of Tongji Medical University. The experimental method:

1.通过上述制备方法获得了三种不同粒径的雄黄粉末样品,其平均粒径分别为500nm(I号样品),200nm(II号样品)和<100nm(III号样品)。1. Obtained three kinds of realgar powder samples with different particle sizes by the above-mentioned preparation method, and its average particle size is respectively 500nm (No. I sample), 200nm (No. II sample) and <100nm (No. III sample).

2.用1%羧甲基纤维素钠水溶液作为助悬剂配制不同雄黄样品的稳定悬浮液,并分别按1.25g/Kg、0.75g/Kg、0.25g/Kg体重三个不同剂量向昆明种小白鼠腹腔注射给药,每组实验动物数为5只,共九组,考察不同时间小鼠的不良反应和死亡情况。2. prepare the stable suspension of different realgar samples with 1% sodium carboxymethylcellulose aqueous solution as suspending agent, and press three different doses of 1.25g/Kg, 0.75g/Kg, 0.25g/Kg body weight respectively to Kunming kind The mice were given intraperitoneal injection, and the number of experimental animals in each group was 5, a total of nine groups, and the adverse reactions and death of the mice at different times were investigated.

3.从荷瘤种鼠腹腔抽取S180腹水瘤细胞,用无菌生理盐水稀释至每毫升6×107细胞混悬液。于试管中向细胞混悬液分别加入不同剂量的雄黄悬浮液,37℃下培养,并不时摇动。用台盼兰染色法考察不同时间肿瘤细胞的形态变化和死亡情况。结果与讨论:3. Extract S 180 ascites tumor cells from the peritoneal cavity of tumor-bearing mice, and dilute them to 6×10 7 cell suspension per ml with sterile saline. Add different doses of realgar suspension to the cell suspension in the test tube, incubate at 37°C, and shake it from time to time. The morphological changes and death of tumor cells at different times were observed by trypan blue staining. Results and discussion:

急性毒性I号样品三个不同剂量组在所考察的时间(1-24小时)内均未见动物死亡,也无明显不良反应。II号、III号样品结果相似,0.25g/Kg剂量组在所考察的时间(1-24小时)内均未见动物死亡,也无明显不良反应;0.75g/Kg剂量组给药24小时后20%动物死亡;1.25g/Kg剂量组给药4小时后动物全部死亡。结果表明不同粒径的雄黄样品,其急性毒性:III号样品(<100nm)≈II号样品(200nm)>>I号样品(500nm)抑瘤作用:25mg/ml剂量组,三种雄黄与细胞作用10分钟后,镜下检查均出现不同程度的细胞形态改变,如细胞膜皱折,但均末见细胞死亡。2小时后不同粒径的雄黄粉末对S180肿瘤细胞的毒杀作用结果见表1。No animal death or obvious adverse reaction was observed in the three different dose groups of the acute toxicity No. I sample within the investigated time (1-24 hours). No. II and No. III sample results are similar, and the 0.25g/Kg dose group has no animal death in the time (1-24 hours) investigated, and there is no obvious adverse reaction; 20% of the animals died; all animals in the 1.25g/Kg dose group died 4 hours after administration. The result shows that realgar samples of different particle sizes, its acute toxicity: No. III sample (<100nm) ≈ No. II sample (200nm) >> No. I sample (500nm) antitumor effect: 25mg/ml dosage group, three kinds of realgar and cell After acting for 10 minutes, microscopic examination showed different degrees of cell morphology changes, such as cell membrane wrinkling, but no cell death was seen. Table 1 shows the toxic effect of realgar powder with different particle sizes on S180 tumor cells after 2 hours.

   表I  不同粒径的雄黄粉末对S180肿瘤细胞的毒杀作用(2小时)剂量              25mg/ml 20mg/ml 15mg/ml 10mg/ml 5mg/mlI样品(500nm)        90%    89%    60%    8%     12%II样品(200nm)       100%   95%    92%    90%    87%III样品(<100nm)    100%   95%    93%    93%    70%The poisonous effect ( 2 hours) dosage 25mg/ml 20mg/ml 15mg/ml 10mg/ml 5mg/mlI sample (500nm) 90% 89% 60% 8% 12 %II sample (200nm) 100% 95% 92% 90% 87%III sample (<100nm) 100% 95% 93% 93% 70%

说明(以作用2小时为例),不同粒径的雄黄样品,对S180肿瘤细胞的毒杀作用强弱次序为:III号样品(<100nm)≈II号样品(200nm)>>I号样品(500nm)上述结果表明矿物中药雄黄的抑瘤作用存在明显的尺寸效应。实验(2)雄黄诱导人脐静脉内皮细胞系ECV-304凋亡的尺寸效应Illustrate (take action 2 hours as example), the realgar samples of different particle diameters, to S 180 tumor cell poisonous action intensity order is: No. III sample (<100nm) ≈ No. II sample (200nm) >> No. I sample (500nm) The above results indicated that the antitumor effect of realgar, a mineral traditional Chinese medicine, had an obvious size effect. Experiment (2) Size Effect of Realgar Induced Apoptosis of Human Umbilical Vein Endothelial Cell Line ECV-304

肿瘤血管形成是肿瘤生长和转移的病理基础。肿瘤血管生成抑制剂(tumor angiogenesis inhibitor,TAI)是一类能破坏或抑制血管生成,有效地阻止肿瘤的生长和转移的药物。Tumor angiogenesis is the pathological basis of tumor growth and metastasis. Tumor angiogenesis inhibitors (tumor angiogenesis inhibitor, TAI) is a class of drugs that can destroy or inhibit angiogenesis, and effectively prevent tumor growth and metastasis.

本实验研究不同粒径的雄黄颗粒对ECV-304细胞存活率,凋亡的影响。方法将粒径分别为<100nm,150nm,200nm,500nm的雄黄颗粒与细胞共同培养,采用MTT方法研究雄黄浓度分别为5×10-8mol/L,10×10-8mol/L,20×10-8mol/L条件下的细胞存活率:荧光显微镜观察法,琼脂糖凝胶电泳法和流式细胞检测法定性定量检测不同粒径的雄寅在20×10-8mol/L浓度下诱导的细胞凋亡。结果:(1)在分别处理2,4,6,8小时条件下,<100nm和150nm的雄黄在所研究的三个浓度下均可显著降低细胞存活率,且呈现时间效应和浓度效应,而200nm,500nm的雄黄在相同条件下对细胞存活率无明显影响.见附图A,B,C:“雄黄对内皮细胞ECV-304存活率的影响”,其中A的雄黄浓度为5×10-8mol/L,B为10×10-8mol/L,C为20×10-8mol/L,纵座标为平均百分存活率,横座标为培养时间(小时);各条曲线◆表示对照组,■表示<100nm雄黄组,△表示150nm雄黄组,×表示200nm雄黄组,□表示500nm雄黄组;(2)以上述四种不同粒径的雄黄在20×10-8mol/L浓度下处理细胞8小时后,荧光染料亚啶橙染色,荧光显微镜观察细胞形态,结果表明在粒径<100nm,150mn作用下,细胞出现明显的凋亡现象:细胞膜发泡和皱缩,细胞体积变小,凋亡小体形成,染色质紧缩,另两种粒径雄寅处理细胞未观寨到明显凋亡现象;经<100nm,150nm雄黄处理的细胞的DNA凝胶电泳显示出典型的凋亡特征:DNA有规律断裂形成的梯状图谱;流式细胞仪检测处理后的细胞,细胞周期的G1期前有亚2倍体的凋亡峰,凋亡峰面积统计学结果表明,对应粒径<100nm-500nm,凋亡率分别为:68.15%,49.62%,7.51%,5.21%。In this experiment, the effects of realgar granules with different particle sizes on the survival rate and apoptosis of ECV-304 cells were studied. Methods Realgar granules with particle diameters of <100nm, 150nm, 200nm, and 500nm were co-cultured with cells, and the concentration of realgar was 5×10 -8 mol/L, 10×10 -8 mol/L, 20× Cell viability under the condition of 10 -8 mol/L: Fluorescence microscope observation, agarose gel electrophoresis and flow cytometry to qualitatively and quantitatively detect males with different particle sizes at a concentration of 20×10 -8 mol/L induced apoptosis. Results: (1) Under the conditions of 2, 4, 6, and 8 hours of treatment respectively, realgar <100nm and 150nm could significantly reduce the cell survival rate at the three concentrations studied, and showed time effects and concentration effects, while 200nm and 500nm realgar had no obvious effect on the cell survival rate under the same conditions. See attached drawings A, B, C: "Effects of realgar on the survival rate of ECV-304 endothelial cells", where the concentration of realgar in A is 5×10 - 8 mol/L, B is 10×10 -8 mol/L, C is 20×10 -8 mol/L, the ordinate is the average percent survival rate, and the abscissa is the culture time (hours); each curve indicates the control group, ■ indicates the <100nm realgar group, △ indicates the 150nm realgar group, × indicates the 200nm realgar group, and □ indicates the 500nm realgar group; After the cells were treated at the concentration for 8 hours, the fluorescent dye was stained with pyridine orange, and the cell morphology was observed under the fluorescence microscope. The results showed that the cells showed obvious apoptosis when the particle size was less than 100nm and 150nm: the cell membrane foamed and shrunk, and the cell volume Smaller, apoptotic bodies formed, chromatin tightened, and the other two particle sizes of males treated cells did not show obvious apoptosis; DNA gel electrophoresis of cells treated with <100nm and 150nm realgar showed typical apoptosis Apoptotic features: a ladder-like pattern formed by regular DNA breaks; flow cytometry detected the treated cells, and there was a sub-diploid apoptotic peak before the G1 phase of the cell cycle, and the statistical results of the apoptotic peak area showed that the corresponding granule diameter <100nm-500nm, the apoptosis rates were: 68.15%, 49.62%, 7.51%, 5.21%.

本研究表明,粒径分别为<100nm,150nm的雄黄可通过诱导细胞凋亡的方式降低内皮细胞存活率,这一结果提示小粒径雄黄可望成为一类崭新的,高效低毒的肿瘤血管生成抑制剂。This study shows that realgar with a particle size of <100nm and 150nm can reduce the survival rate of endothelial cells by inducing apoptosis. This result suggests that realgar with small particle size is expected to become a new type of tumor vascular with high efficiency and low toxicity. Generate inhibitors.

纳米技术是一门在0.1~100nm空间尺度内操纵原子和分子,对材料进行加工、制造出具有特定功能产品的高新技术,它被认为是“今后十年最可能使人类发生巨大变化的十项技术”之一。当颗粒尺寸进入纳米量级时,由于量子尺寸效应和表面效应,纳米材料呈现出许多新奇的物理、化学和生物学特性。本发明所涉及的是把纳米技术引入到中药雄黄的制备,即把雄黄制成纳米级的超细微粉,从而赋予雄黄以更高的药效。Nanotechnology is a high-tech that manipulates atoms and molecules within the spatial scale of 0.1-100nm, processes materials, and manufactures products with specific functions. technology". When the particle size enters the nanoscale, due to the quantum size effect and surface effect, nanomaterials present many novel physical, chemical and biological properties. The invention relates to the introduction of nanotechnology into the preparation of realgar, that is, making realgar into nano-scale ultrafine powder, so as to endow realgar with higher drug efficacy.

附图A,B,C:雄黄对内皮细胞ECV-304存活率的影响,其中A的雄黄浓度为5×10-8mol/L,B为10×10-8mol/L,C为20×10-8mol/L,纵座标为平均百分存活率,横座标为培养时间(小时);各条曲线◆表示对照组,■表示100nm雄黄组,△表示150nm雄黄组,×表示200nm雄黄组,□表示500nm雄黄组。Figures A, B, C: Effects of realgar on the survival rate of endothelial cells ECV-304, where the concentration of realgar in A is 5×10 -8 mol/L, B is 10×10 -8 mol/L, and C is 20× 10 -8 mol/L, the ordinate is the average percent survival rate, and the abscissa is the culture time (hours); each curve ◆ indicates the control group, ■ indicates the 100nm realgar group, △ indicates the 150nm realgar group, and × indicates the 200nm realgar group, □ indicates the 500nm realgar group.

实例:取1.5公斤的雄黄与15公斤的磨球放置于配有深冷外套的真空或惰性气体气氛的球磨罐中,液氮流量为50毫升/分钟,控制温度为0℃,高能球磨机的转速为300RPM(转/分),运转20小时,即获得平均粒径小于100纳米的雄黄粉末,并得到电子显微镜观察的证明。Example: Take 1.5 kg of realgar and 15 kg of balls and place them in a vacuum or inert gas atmosphere ball mill jar equipped with a cryogenic jacket. The flow rate of liquid nitrogen is 50 ml/min, the temperature is controlled at 0°C, and the speed of the high-energy ball mill is Be 300RPM (rev/min), run 20 hours, promptly obtain the realgar powder that average particle diameter is less than 100 nanometers, and obtain the proof of electron microscope observation.

Claims (3)

1. the Powdered Realgar as Chinese medicine is characterized in that, the particle diameter of Powdered Realgar is 1~100 nanometer.
2. method for preparing Powdered Realgar as claimed in claim 1, it is characterized in that: this method is that the Realgar material powder is placed the high energy ball mill jar, make ball powder ratio remain on 15: 1~5: 1 ratio, be filled with vacuum or inert gas atmosphere in jar, the rotating speed and the time of control high energy ball mill, make it in 200~400RPM and 2~60 hours scopes, the control temperature, span of control is-50 ℃~100 ℃, and temperature is to control by the amount that adjusting is injected into the double-layer sleeve liquid nitrogen of high energy ball mill.
3. method for preparing pulverous Realgar as claimed in claim 1, this method is that the Realgar material powder is placed in the jet mill, in inert gas atmosphere, pulverize, it is characterized in that, the control temperature, span of control is-50 ℃~100 ℃, and temperature is to control by the amount of liquid nitrogen that adjusting is injected in the jet mill.
CN 00116045 2000-09-25 2000-09-25 Nanometer-size realgar and its preparation Expired - Fee Related CN1116028C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 00116045 CN1116028C (en) 2000-09-25 2000-09-25 Nanometer-size realgar and its preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 00116045 CN1116028C (en) 2000-09-25 2000-09-25 Nanometer-size realgar and its preparation

Publications (2)

Publication Number Publication Date
CN1288723A CN1288723A (en) 2001-03-28
CN1116028C true CN1116028C (en) 2003-07-30

Family

ID=4585468

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 00116045 Expired - Fee Related CN1116028C (en) 2000-09-25 2000-09-25 Nanometer-size realgar and its preparation

Country Status (1)

Country Link
CN (1) CN1116028C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100374463C (en) * 2005-03-05 2008-03-12 广西师范大学 Method for preparing nano-realgar colloid and nano-realgar by using biological macromolecular template to control morphology and particle size

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003037359A1 (en) * 2001-10-29 2003-05-08 Chengdu Somo Namotechnology Co., Ltd. Nanoparticle of insoluble medicinal components and method to produce thereof
CN1302773C (en) * 2002-07-09 2007-03-07 成都思摩纳米技术有限公司 Method for preparing nanometer suspension of DHA
CN1299668C (en) * 2003-07-08 2007-02-14 华中科技大学 Nanometer realgar solid dispersion and its preparation method
CN108236613A (en) * 2016-12-27 2018-07-03 兰州大学 Realgar microorganism extracting liquid is preparing the application in inhibiting angiogenesis drug
CN107320489A (en) * 2017-04-15 2017-11-07 安徽天康(集团)股份有限公司 The application of a kind of nanometer-size realgar medically and preparation method thereof
CN106890191A (en) * 2017-04-27 2017-06-27 兰州大学 A kind of biological concocting method of nanometer-size realgar

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100374463C (en) * 2005-03-05 2008-03-12 广西师范大学 Method for preparing nano-realgar colloid and nano-realgar by using biological macromolecular template to control morphology and particle size

Also Published As

Publication number Publication date
CN1288723A (en) 2001-03-28

Similar Documents

Publication Publication Date Title
Hameed et al. Shape-dependent significant physical mutilation and antibacterial mechanisms of gold nanoparticles against foodborne bacterial pathogens (Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus) at lower concentrations
Katas et al. Antibacterial activity of biosynthesized gold nanoparticles using biomolecules from Lignosus rhinocerotis and chitosan
Panda et al. Green synthesis of silver nanoparticles and its potential effect on phytopathogens
Kung et al. Silver decorated copper oxide (Ag@ CuO) nanocomposite enhances ROS-mediated bacterial architecture collapse
Jana et al. The antibacterial and anticancer properties of zinc oxide coated iron oxide nanotextured composites
Huang et al. γ-Ray assisted synthesis of silver nanoparticles in chitosan solution and the antibacterial properties
Zhu et al. Controlled in-situ synthesis of silver nanoparticles in natural cellulose fibers toward highly efficient antimicrobial materials
CN106880593B (en) A kind of nanometer antibacterial agent loaded with nanometer silver and curcumin at the same time and its preparation method and application
Safarpoor et al. Ultrasound-assisted extraction of antimicrobial compounds from Thymus daenensis and Silybum marianum: Antimicrobial activity with and without the presence of natural silver nanoparticles
Bajaj et al. Stabilized cationic dipeptide capped gold/silver nanohybrids: Towards enhanced antibacterial and antifungal efficacy
Hindumathi et al. Novel nano-cocoon like structures of polyethylene glycol–multiwalled carbon nanotubes for biomedical applications
Ghelani et al. Synthesis and characterization of Aluminium Oxide nanoparticles
Kasinathan et al. Facile synthesis of highly biologically active chitosan functionalized 2D WS2 nanocomposite anchored with palladium nanoparticles for antibacterial and anticancer activity: In-vitro biomedical evaluation
Cui et al. Preparation of graphene oxide with silver nanowires to enhance antibacterial properties and cell compatibility
Allafchian et al. Synthesis, characterization and antibacterial effect of poly (acrylonitrile/maleic acid)–silver nanocomposite
Mudhafar et al. Microwave-assisted green synthesis of Ag nanoparticles using leaves of Melia dubia (Neem) and its antibacterial activities
Abuelsamen et al. Novel Pluronic F‐127‐coated ZnO nanoparticles: Synthesis, characterization, and their in‐vitro cytotoxicity evaluation
CN1116028C (en) Nanometer-size realgar and its preparation
Xu et al. Supercritical carbon dioxide-assisted nanonization of dihydromyricetin for anticancer and bacterial biofilm inhibition efficacies
Majerič et al. Formation of non-toxic Au nanoparticles with bimodal size distribution by a modular redesign of ultrasonic spray pyrolysis
Halevas et al. Chitosan encapsulation of essential oil “cocktails” with well-defined binary Zn (II)-Schiff base species targeting antibacterial medicinal nanotechnology
Chandran et al. Solid-state synthesis of silver nanowires using biopolymer thin films
Islam et al. Structural and antimicrobial response of chitosan capped gold nanostructures employing two different synthetic routes
Zhang et al. Incorporation of Ag NPs/palygorskite into chitosan/glycyrrhizic acid films as a potential antibacterial wound dressing
Amjad et al. Preparation and characterization of magnetic nanoparticles loaded with antimicrobial agent

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee